Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy

Pek Keng Koh*, Corinne Faivre-Finn, Fiona H. Blackhall, Dirk De Ruysscher

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)626-640
JournalCancer Treatment Reviews
Issue number6
Publication statusPublished - Oct 2012


  • Non-small cell lung cancer
  • Targeted agents
  • Chemoradiotherapy
  • EGFR inhibitors
  • Antiangiogenic agents
  • Phase I trials
  • Preclinical models
  • Radiotherapy
  • Combined modality treatment

Cite this